Skip to content

AlboGraft Polyester Vascular Graft AMC1608Recalls & reported problems

Lemaitre Vascular, Inc. · AlboGraft Polyester Vascular Graft 16cmx8mm · Class 2 · Implant

All models of AlboGraft Polyester Vascular Graft (11)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00840663103454), received between Jun 17, 2016 and Jun 26, 2024 — classified as 4 injuries.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Fluid/Blood Leak1
  • Leak/Splash1
  • Material Puncture/Hole1

Patient problems

  • Blood Loss1
  • Hemorrhage/Blood Loss/Bleeding1
  • Irritation1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 26, 2024Fluid/Blood Leak; Fluid/Blood Leak

    IT WAS REPORTED THAT THE ALBOGRAFT WALL WAS LEAKING AFTER BEING CLOSED WITH SUTURES FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) PROCEDURE. LEAKAGE OCCURRED FROM THE GRAFT RESULTING IN LONGER OPERATION TIME AND BLOOD LOSS. AN ALTERNATE GRAFT WAS USED TO COMPLETE THE PROCEDURE. NO FURTHER COMPLICATION OR INJURY WAS REPORTED TO THE PATIENT.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 19617006 ↗
  • InjuryJun 10, 2020Material Puncture/Hole; Material Puncture/Hole

    INTRAOPERATIVELY, A HOLE WAS NOTICED IN THE GRAFT. THE HOLE WAS 3-4MM IN SIZE. ON ONE PICTURE IS A 1.2MM DULL- HEADED CANNULA IN THE HOLE OF THE GRAFT. THE HOLE WAS SEWN OVER. THE PATIENT WAS STILL IN THE OPERATION ROOM, WHEN THEY CALLED US. THERE WAS NO IMPACT ON PATIENT'S HEALTH AS THE RESULT OF THIS INCIDENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10138111 ↗
  • InjuryDec 13, 2018Adverse Event Without Identified Device or Use Problem

    A FEW YEARS AGO ( EXACT DATE UNKNOWN), A PATIENT RECEIVED A BIFURCATED AORTIC PROSTHESIS ( FROM A DIFFERENT MANUFACTURER ). THE PATIENT WAS DIAGNOSED WITH A PERIGRAFT SEROMA FROM THIS GRAFT. ON (B)(6) 2017, THE PROSTHESIS WAS REPLACED WITH AN ALBOGRAFT PROSTHESIS ( CATALOG# AMC1608; LOT# 180381 SERIAL NUMBER# (B)(4)). THE PATIENT HAD AN ALLERGIC REACTION TO THIS GRAFT AS WELL. SO, THE PATIENT WAS TREATED FOR AN ALLERGIC REACTION. THE PATIENT RESPONDED WELL TO MEDICATION. HOWEVER, SINCE THE BEGINNING OF (B)(6) 2018, THE PATIENT DID NOT RESPOND WELL TO THE PRESCRIBED MEDICATION. A BLOOD TEST CONDUCTED ON THE PATIENT'S BLOOD SAMPLE DETECTED PRESENCE OF METHY- PROPYL-4-HYDROXYBENZOATE.

    Patient problems: Irritation

    MAUDE report 8162158 ↗
  • InjuryJun 17, 2016Leak/Splash; Leak/Splash

    THE GRAFT WAS LEAKING DURING THE IMPLANTATION. THE PHYSICIAN HAD TO USE THE BLOOD CIRCULATING MACHINE FOR BLOOD TRANSFUSION (ABOUT 800 CC). THE BLEEDING WAS STOPPED WITH CELLULOSE WADDING. THE GRAFT REMAINS IMPLANTED. PATIENT IS OKAY.

    Patient problems: Blood Loss

    MAUDE report 5732537 ↗

Other Graft, Vascular, Synthetic/Biologic Composite devices

All Graft, Vascular, Synthetic/Biologic Composite devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page